Temat: "Deficiency" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
Autorzy:: McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Harrison C; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Binnie R; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Lewis RD; Health Economics and Outcomes Research Ltd, Cardiff, UK.
Cohen-Solal A; Hospital Lariboisière, AP-HP, INSERM U948 MASCOT, Université Paris Cité, Paris, France.
Lund LH; Department of Medicine, Karolinska Institutet and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Ohlsson M; Department of Internal Medicine, Malmö University Hospital, Malmö, Sweden.
von Haehling S; Department of Cardiology and Pneumology, University of Göttingen Medical Center and German Center for Cardiovascular Research (DZHK), Göttingen, Germany.
Comin-Colet J; Cardiology Department, Hospital Universitari Bellvitge, University of Barcelona and IDIBELL, Barcelona, Spain.
Pascual-Figal DA; Cardiology Department, Hospital Virgen de la Arrixaca, University of Murcia, Murcia, Spain; and Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Wächter S; CSL Vifor, Glattbrugg, Switzerland.
Dorigotti F; CSL Vifor, Glattbrugg, Switzerland.
de Arellano AR; HEOR, CSL Vifor, Glattbrugg, Switzerland.
Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wrocław, Poland.
Jankowska EA; Institute of Heart Diseases, University Hospital, Wrocław, Poland.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2023 Mar; Vol. 25 (3), pp. 389-398. Date of Electronic Publication: 2023 Mar 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Heart Failure*/drug therapy
Heart Failure*/epidemiology
Heart Failure*/complications
Iron Deficiencies*
Anemia, Iron-Deficiency*/drug therapy
Anemia, Iron-Deficiency*/epidemiology
Anemia, Iron-Deficiency*/complications
Humans ; Patient Discharge ; Cost-Benefit Analysis ; Stroke Volume ; Quality of Life ; Ventricular Function, Left ; Ferric Compounds/therapeutic use ; Hospitalization ; Maltose/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Causative alleles for chondrodysplastic dwarfism, factor XI deficiency, and factor XIII deficiency in the Kumamoto sub-breed of Japanese Brown cattle.
Autorzy:: Matsumoto H; Department of Animal Science, School of Agriculture, Tokai University, Kumamoto, Japan.
Kimura S; Course of Agricultural Sciences, Graduate School of Agriculture, Tokai University, Kumamoto, Japan.
Saito R; Department of Animal Science, School of Agriculture, Tokai University, Kumamoto, Japan.
Takeichi M; Department of Animal Science, School of Agriculture, Tokai University, Kumamoto, Japan.
Kashimura A; Department of Animal Science, School of Agriculture, Tokai University, Kumamoto, Japan.
Inenaga T; Department of Animal Science, School of Agriculture, Tokai University, Kumamoto, Japan.; Pokaż więcej
Źródło:: Animal science journal = Nihon chikusan Gakkaiho [Anim Sci J] 2023 Jan-Dec; Vol. 94 (1), pp. e13882.
Typ publikacji:: Journal Article
MeSH Terms:: Factor XI Deficiency*/genetics
Factor XI Deficiency*/veterinary
Factor XIII Deficiency*/genetics
Factor XIII Deficiency*/veterinary
Dwarfism*/genetics
Dwarfism*/veterinary
Cattle Diseases*/genetics
Humans ; Cattle/genetics ; Animals ; Alleles ; Breeding

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions.
Autorzy:: Kalogeropoulos AP; Division of Cardiology, Department of Medicine, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY, USA.
Lewis GD; Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2023 Apr; Vol. 25 (4), pp. 538-540. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:: Heart Failure*/complications
Heart Failure*/drug therapy
Hematinics*/therapeutic use
Anemia, Iron-Deficiency*/drug therapy
Humans ; Iron/therapeutic use ; Administration, Intravenous ; Dietary Supplements

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Dosing of iron supplementation for iron-deficient patients with heart failure: should we prefer more intensive or less intensive repletion targets?
Autorzy:: Packer M; Baylor Heart and Vascular Institute, Dallas, TX, USA.; Imperial College, London, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2023 Apr; Vol. 25 (4), pp. 454-456. Date of Electronic Publication: 2023 Mar 08.
Typ publikacji:: Journal Article
MeSH Terms:: Heart Failure*/complications
Heart Failure*/drug therapy
Anemia, Iron-Deficiency*/drug therapy
Humans ; Iron ; Dietary Supplements

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A pharmacokinetic-pharmacodynamic model for chemoprotective agents against malaria.
Autorzy:: Cherkaoui-Rbati MH; Medicines for Malaria Venture, Geneva, Switzerland.
Andenmatten N; Medicines for Malaria Venture, Geneva, Switzerland.
Burgert L; University of Basel, Basel, Switzerland.
Egbelowo OF; Division of Clinical Pharmacology, Department of Medicine, The University of Texas at Austin, Texas, Austin, USA.
Fendel R; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Fornari C; AstraZeneca, Cambridge, UK.
Gabel M; Center for Modelling and Simulation in the Biosciences, BioQuant-Center, University of Heidelberg, Heidelberg, Germany.
Ward J; Department of Mathematical Sciences, University of Loughborough, Loughborough, UK.
Möhrle JJ; Medicines for Malaria Venture, Geneva, Switzerland.
Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Jan; Vol. 12 (1), pp. 50-61. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Malaria*/drug therapy
Malaria*/prevention & control
Glucosephosphate Dehydrogenase Deficiency*/chemically induced
Glucosephosphate Dehydrogenase Deficiency*/drug therapy
Child ; Humans ; Female ; Pregnancy ; Enzyme Inhibitors ; Liver

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure.
Autorzy:: Caravita S; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.; Department of Management, Information and Production Engineering, University of Bergamo, Dalmine, Italy.
Faini A; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Vignati C; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Pelucchi S; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Salvioni E; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Cattadori G; MultiMedica IRCCS, Milan, Italy.
Baratto C; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Torlasco C; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Contini M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Villani A; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Malfatto G; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Perger E; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.
Lombardi C; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Piperno A; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Agostoni P; Centro Cardiologico Monzino, IRCCS, Milan, Italy.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Parati G; Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Ospedale San Luca, Milan, Italy.; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1940-1949. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia, Iron-Deficiency*/complications
Anemia, Iron-Deficiency*/drug therapy
Heart Failure*/complications
Heart Failure*/drug therapy
Iron Deficiencies*
Sleep Apnea Syndromes*/complications
Male ; Humans ; Female ; Stroke Volume ; Ventricular Function, Left ; Maltose ; Ferric Compounds ; Chronic Disease ; Iron/therapeutic use ; Hemoglobins ; Oxygen

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial.
Autorzy:: Metra M; Insitute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Jankowska EA; Institute of Heart Diseases, Wroclaw Medical University, Poland.; Institute of Heart Diseases, University Hospital, Wroclaw, Poland.
Pagnesi M; Insitute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Germany.
Butler J; University of Mississippi Medical Center, Jackson, MS, USA.
Dorigotti F; Vifor Pharma Ltd, Glattbrugg, Switzerland.
Fabien V; Vifor Pharma Ltd, Glattbrugg, Switzerland.
Filippatos G; National and Kapodistrian University of Athens, School of Medicine, Athens University Hospital Attikon, Department of Cardiology, Athens, Greece.
Kirwan BA; Department of Clinical Research, SOCAR Research SA, Nyon, Switzerland.; London School of Hygiene and Tropical Medicine, University College London, London, UK.
Macdougall IC; Department of Renal Medicine, King's College Hospital, London, UK.
Rosano G; Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Ruschitzka F; Department of Cardiology, University Heart Center, University Hospital Zürich and University of Zürich, Zürich, Switzerland.
Tomasoni D; Insitute of Cardiology, ASST Spedali Civili, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
van der Meer P; Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Poland.; Pokaż więcej
Corporate Authors:: AFFIRM-AHF Investigators
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 Oct; Vol. 24 (10), pp. 1928-1939. Date of Electronic Publication: 2022 Sep 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Iron Deficiencies*
Anemia, Iron-Deficiency*/etiology
Heart Failure*/complications
Heart Failure*/drug therapy
Heart Failure*/chemically induced
Humans ; Male ; Quality of Life ; Maltose ; Ferric Compounds

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure.
Autorzy:: Graham FJ; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Masini G; Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Pellicori P; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Cleland JGF; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Greenlaw N; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Friday J; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Kazmi S; Hull University Teaching Hospitals NHS Trust, Hull, UK.
Clark AL; Hull University Teaching Hospitals NHS Trust, Hull, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 807-817. Date of Electronic Publication: 2021 Jul 01.
Typ publikacji:: Journal Article
MeSH Terms:: Anemia*/complications
Anemia*/epidemiology
Anemia, Iron-Deficiency*/etiology
Heart Failure*/complications
Heart Failure*/epidemiology
Iron Deficiencies*
Aged ; Chronic Disease ; Female ; Humans ; Iron ; Male ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
Autorzy:: Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Center for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Institute of Heart Diseases, University Hospital in Wroclaw, Poland.
Ponikowski P; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Khan MS; Division of Cardiology, Duke University Medical Center, Durham, NC, USA.
Friede T; Göttingen, Germany; DZHK (German Center for Cardiovascular Research), Göttingen partner site, University Medical Center Göttingen, Göttingen, Germany.
Jankowska EA; Institute of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.
Fabien V; Vifor Pharma Ltd., Glattbrugg, Switzerland.
Goehring UM; Vifor Pharma Ltd., Glattbrugg, Switzerland.
Metra M; Cardiology, University and Civil Hospital, Brescia, Italy.
Piña IL; Central Michigan University, Mount Pleasant, MI, USA.
Coats AJS; University of Warwick, Coventry, UK.
Rosano G; Centre for Clinical and Basic Research, Department of Medical Sciences, IRCCS San Raffaele Pisana, Rome, Italy.
Dorigotti F; Vifor Pharma Ltd., Glattbrugg, Switzerland.
Comin-Colet J; Department of Cardiology, Bellvitge University Hospital; IDIBELL, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Van Veldhuisen DJ; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Filippatos GS; Medical School University of Cyprus, Nicosia, Cyprus.; School of Medicine of National and Kapodistrian University of Athens, Athens University Hospital Attikon, Athens, Greece.
Butler J; Department of Medicine, University of Mississippi, Jackson, MS, USA.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 833-842. Date of Electronic Publication: 2022 Apr 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia, Iron-Deficiency*/drug therapy
Heart Failure*/drug therapy
Iron Deficiencies*
Ventricular Dysfunction, Left*/drug therapy
Ferric Compounds ; Humans ; Iron/therapeutic use ; Maltose/analogs & derivatives ; Maltose/therapeutic use ; Stroke Volume ; Treatment Outcome ; Walk Test

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Fluctuating iron levels in heart failure: when and where to look at?
Autorzy:: Alnuwaysir RIS; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Grote Beverborg N; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 May; Vol. 24 (5), pp. 818-820. Date of Electronic Publication: 2022 May 04.
Typ publikacji:: Editorial; Comment
MeSH Terms:: Anemia, Iron-Deficiency*
Heart Failure*
Humans ; Iron

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study.
Autorzy:: Alnuwaysir RIS; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Grote Beverborg N; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Hoes MF; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Markousis-Mavrogenis G; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Gomez KA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
van der Wal HH; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Cleland JGF; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow and National Heart & Lung Institute, Imperial College, London, UK.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Lang CC; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
Ng LL; Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.; NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, UK.
Ponikowski P; Department of Heart Diseases, Wroclaw Medical University, and Cardiology Department, Military Hospital, Wroclaw, Poland.
Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 Jan; Vol. 24 (1), pp. 192-204. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia*/complications
Anemia*/epidemiology
Anemia, Iron-Deficiency*/complications
Anemia, Iron-Deficiency*/epidemiology
Cardio-Renal Syndrome*/epidemiology
Heart Failure*/complications
Heart Failure*/epidemiology
Iron Deficiencies*
Humans ; Male ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
Autorzy:: Becher PM; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.; German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Berlin, Germany.
Schrage B; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.; German Center of Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Berlin, Germany.
Benson L; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Fudim M; Department of Medicine, Duke University Medical Center, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA.
Corovic Cabrera C; Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.; Department of Cardiology, Södersjukhuset, Stockholm, Sweden.
Dahlström U; Department of Cardiology and Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.
Rosano GMC; St George's Hospital Medical School, London, UK.; IRCCS San Raffaele Roma, Rome, Italy.
Jankowska EA; Department of Heart Diseases, Wroclaw Medical University, and Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
Anker SD; Department of Cardiology (CVK); and Berlin Institute of Health Center for Regenerative Therapies (BCRT); German Centre for Cardiovascular Research (DZHK) partner site Berlin; Charité Universitätsmedizin Berlin, Berlin, Germany.
Lund LH; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.; Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Nov; Vol. 23 (11), pp. 1844-1854. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia, Iron-Deficiency*/complications
Anemia, Iron-Deficiency*/drug therapy
Anemia, Iron-Deficiency*/epidemiology
Heart Failure*/complications
Heart Failure*/drug therapy
Heart Failure*/epidemiology
Iron Deficiencies*
Ferric Compounds/therapeutic use ; Humans ; Iron/therapeutic use ; Maltose/therapeutic use ; Quality of Life ; Registries ; Stroke Volume ; Sweden/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Cardiac energetics in patients with chronic heart failure and iron deficiency: an in-vivo P magnetic resonance spectroscopy study.
Autorzy:: Papalia F; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, James Black Centre, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK.
Jouhra F; Guy's and St Thomas' NHS Foundation Trust, London, UK.; Lewisham & Greenwich NHS Foundation Trust, London, UK.; St George's University Hospitals NHS Foundation Trust, London, UK.
Amin-Youssef G; King's College Hospital NHS Foundation Trust, London, UK.
Shah AM; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, James Black Centre, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK.; King's College Hospital NHS Foundation Trust, London, UK.
Charles-Edwards G; School of Imaging Sciences and Biomedical Engineering, King's College, London, UK.
Okonko DO; King's College London British Heart Foundation Centre of Excellence, School of Cardiovascular Medicine and Sciences, James Black Centre, London, UK.; Guy's and St Thomas' NHS Foundation Trust, London, UK.; King's College Hospital NHS Foundation Trust, London, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 Apr; Vol. 24 (4), pp. 716-723. Date of Electronic Publication: 2022 Mar 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia*/complications
Anemia, Iron-Deficiency*/complications
Heart Failure*
Iron Deficiencies*
Adenosine Triphosphate ; Chronic Disease ; Humans ; Magnetic Resonance Spectroscopy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Iron deficiency testing and treatment in heart failure: the eyes are useless when the mind is blind.
Autorzy:: Miñana G; Cardiology Department and Heart Failure Unit, Hospital Clínico Universitario de Valencia, INCLIVA, Universitat de Valencia, Valencia, Spain.; CIBER Cardiovascular, Madrid, Spain.
Bayés-Genís A; CIBER Cardiovascular, Madrid, Spain.; Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain.; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
Núñez J; Cardiology Department and Heart Failure Unit, Hospital Clínico Universitario de Valencia, INCLIVA, Universitat de Valencia, Valencia, Spain.; CIBER Cardiovascular, Madrid, Spain.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Nov; Vol. 23 (11), pp. 1855-1857. Date of Electronic Publication: 2021 Oct 27.
Typ publikacji:: Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:: Anemia, Iron-Deficiency*/diagnosis
Anemia, Iron-Deficiency*/drug therapy
Heart Failure*/drug therapy
Heart Failure*/therapy
Iron Deficiencies*
Ferric Compounds/therapeutic use ; Hospitalization ; Humans ; Maltose/therapeutic use ; Transferrin

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Reply to the letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure'.
Autorzy:: Graham FJ; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Pellicori P; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Cleland JGF; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Clark AL; Hull University Teaching Hospitals NHS Trust, Hull, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Oct; Vol. 23 (10), pp. 1800-1801. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji:: Letter; Comment
MeSH Terms:: Anemia*
Anemia, Iron-Deficiency*/complications
Anemia, Iron-Deficiency*/epidemiology
Heart Failure*/complications
Iron Deficiencies*
Humans ; Prognosis

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Letter regarding the article 'Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure'.
Autorzy:: Zeng DX; Department of Pulmonary and Critical Care Medicine, Suzou Dushu Lake Hospital, Medical Center of Soochow University, Soochow University Affiliated Dushu Lake Hospital, Suzhou, China.
Jiang JH; Department of Pulmonary and Critical Care Medicine, Suzou Dushu Lake Hospital, Medical Center of Soochow University, Soochow University Affiliated Dushu Lake Hospital, Suzhou, China.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Oct; Vol. 23 (10), pp. 1800. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji:: Letter; Comment
MeSH Terms:: Anemia*
Anemia, Iron-Deficiency*/complications
Anemia, Iron-Deficiency*/epidemiology
Heart Failure*/complications
Heart Failure*/epidemiology
Iron Deficiencies*
Humans ; Prognosis

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Iron deficiency contributes to resistance to endogenous erythropoietin in anaemic heart failure patients.
Autorzy:: Tkaczyszyn M; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
Comín-Colet J; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Community Heart Failure Program, Cardiology Department, University Hospital Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Enjuanes C; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Community Heart Failure Program, Cardiology Department, University Hospital Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Moliner P; Bio-Heart Cardiovascular Diseases Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Community Heart Failure Program, Cardiology Department, University Hospital Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Drozd M; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
Sierpiński R; Medical Research Agency, Warsaw, Poland.
Rozentryt P; Silesian Centre for Heart Disease and Silesian Medical University, Zabrze, Poland.
Nowak J; Silesian Centre for Heart Disease and Silesian Medical University, Zabrze, Poland.
Suchocki T; Biostatistics Group, Department of Genetics, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
Banasiak W; Cardiology Department, Centre for Heart Diseases, Military Hospital, Wroclaw, Poland.
Ponikowski P; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Jankowska EA; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Oct; Vol. 23 (10), pp. 1677-1686. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia*
Anemia, Iron-Deficiency*
Erythropoietin*
Heart Failure*
Iron Deficiencies*
Aged ; Aged, 80 and over ; Female ; Hemoglobins/metabolism ; Humans ; Male ; Middle Aged

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
Autorzy:: Sierpinski R; Medical Research Agency, Warsaw, Poland.; Collegium Medicum, Cardinal Wyszyński University in Warsaw, Warsaw, Poland.
Josiak K; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
Suchocki T; Biostatistics Group, Department of Genetics, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.
Wojtas-Polc K; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Department of Cardiology, Military Hospital, Wroclaw, Poland.
Mazur G; Department of Internal Diseases, Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland.
Butrym A; Department of Internal Diseases, Occupational Medicine and Hypertension, Wroclaw Medical University, Wroclaw, Poland.
Rozentryt P; Third Department of Cardiology, Silesian Center for Heart Disease, Zabrze, Poland.
van der Meer P; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Comin-Colet J; Department of Cardiology, Heart Failure Program, Hospital del Mar, Barcelona, Spain.; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
von Haehling S; Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany.
Kosmala W; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.; Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.
Przewlocka-Kosmala M; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.; Department of Cardiology, Wroclaw Medical University, Wroclaw, Poland.
Banasiak W; Department of Cardiology, Military Hospital, Wroclaw, Poland.
Nowak J; Third Department of Cardiology, Silesian Center for Heart Disease, Zabrze, Poland.
Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Anker SD; Division of Applied Cachexia Research, Department of Cardiology, Charité Medical School, Berlin, Germany.
Cleland JGF; Department of Cardiology, Hull York Medical School, University of Hull, Castle Hill Hospital, Kingston-upon-Hull, UK.
Ponikowski P; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.
Jankowska EA; Department of Heart Diseases, Wroclaw Medical University, Wroclaw, Poland.; Centre for Heart Diseases, University Hospital, Wroclaw, Poland.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2021 Jun; Vol. 23 (6), pp. 919-932. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Anemia, Iron-Deficiency*/diagnosis
Anemia, Iron-Deficiency*/epidemiology
Heart Failure*/epidemiology
Biomarkers ; Humans ; Receptors, Transferrin ; Stroke Volume ; Transferrin ; Ventricular Function, Left

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: MicroRNA-122 contributes to lipopolysaccharide-induced acute kidney injury via down-regulating the vitamin D receptor in the kidney.
Autorzy:: He J; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.
Du J; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.
Yi B; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.
Wang J; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhang H; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.
Li YC; Department of Medicine, Division of Biological Sciences, The University of Chicago, Chicago, IL, USA.
Sun J; Department of Nephrology, The Third Xiangya Hospital, Central South University, Changsha, China.; Department of Rheumatology and Immunology, The Third Xiangya Hospital, Central South University, Changsha, China.; Pokaż więcej
Źródło:: European journal of clinical investigation [Eur J Clin Invest] 2021 Aug; Vol. 51 (8), pp. e13547. Date of Electronic Publication: 2021 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Vitamin D Deficiency*/physiopathology
Acute Kidney Injury/*genetics
MicroRNAs/*genetics
Receptors, Calcitriol/*genetics
Acute Kidney Injury/chemically induced ; Animals ; Apoptosis ; Down-Regulation ; HEK293 Cells ; Humans ; Kidney Tubules/cytology ; Lipopolysaccharides ; Male ; Mice ; Mice, Inbred C57BL ; Vitamin D

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Protein restriction during puberty alters nutritional parameters and affects ovarian and uterine histomorphometry in adulthood in rats.
Autorzy:: de Morais Oliveira DA; Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.; Graduate Program in Nutrition, Institute of Biosciences of Botucatu, UNESP, São Paulo, Brazil.
Lupi LA; Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.
Silveira HS; Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.
de Almeida Chuffa LG; Department of Structural and Functional Biology, Institute of Biosciences, UNESP - São Paulo State University, Botucatu, São Paulo, Brazil.; Pokaż więcej
Źródło:: International journal of experimental pathology [Int J Exp Pathol] 2021 Apr; Vol. 102 (2), pp. 93-104. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Estrous Cycle/*physiology
Ovary/*pathology
Protein Deficiency/*physiopathology
Sexual Maturation/*physiology
Uterus/*pathology
Animals ; Female ; Ovary/metabolism ; Protein Deficiency/metabolism ; Protein Deficiency/pathology ; Rats ; Rats, Inbred F344 ; Uterus/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Deficiency"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Publikacja

Język